期刊文献+

滴眼剂人眼部药代动力学研究的方法学探讨 被引量:7

Analysis on the methodology of topical pharmacokinetic study of eyedrops in human eyes
原文传递
导出
摘要 滴眼剂的人眼部药代动力学研究对眼科药物的开发及评价具有重要意义。本文对滴眼剂的眼部药代动力学特征、眼部药代动力学研究的设计要点、泪液及房水中药代动力学研究的设计及实施方法进行探讨。 Ocular pharmacokinetic study of ophthalmic solution in human subjects is of great importance to develop and evaluate ophthalmological drugs. The topical pharmacokinetic characters of eyedrops, key points of designing an ocular pharmacokinetic study, and the methodology of tears and aqueous humor pharmacokinetics are summarized.
作者 武峰 赵秀丽
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第5期395-397,共3页 The Chinese Journal of Clinical Pharmacology
基金 十二五"重大新药创制"国家科技重大专项资助项目(2011ZX09302-007-05)
关键词 滴眼剂 药代动力学 泪液 房水 方法学 eyedrop pharmacokinetic tear aqueous humor methodology
  • 相关文献

参考文献13

  • 1Yasukawa T, Ogura Y, Tabata Y, et a/. Drug delivery systems for vit- reoretinal diseases [J]. Prog Ret in Eye Res, 2004,23:253 -281.
  • 2Achoufi D, Alhanout K, Piccerelle P, et al. Recent advances in ocular drug delivery[J]. Drug Dev Ind Pharm, 2013,39 : 1599 - 1617.
  • 3Ramdas WD, van der Velde N, van der Cammen TJ, et al. Evalua- tion of risk of falls and orthostatic hypotension in older, long- term topical beta- blocker users[ J]. Graefes Arch Clin Exp Ophthalmol, 2009,247 : 1235 - 1241.
  • 4陈祖基.重视眼部给药系统的研究[J].中华眼科杂志,2006,42(4):292-295. 被引量:16
  • 5Lee SB, Geroski DH, Prausnitz MR, et al. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems [ J ]. Exp Eye Res, 2004,78:599 -607.
  • 6Theng J, Zhou L, Tan D, et al. Distribution of cyclosporin A in the cornea after topical or oral administration [ J ]. J Ocul Pharmacol Ther, 2002,18:83 - 88.
  • 7Lai WW, Chu KO, Chan KP, et al. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy [ J ]. Am J Ophthalmol, 2007,144:315 - 318.
  • 8Chiambaretta F, Garraffo R, Elena PP, et al. Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0. 5%, 1.0%, and 1.5% eyedrops ( T1225 ) in healthy volunteers [ J]. Eur J Ophthalmol, 2008,18 : 13 - 20.
  • 9Waltem T, Rinehart M, Krebs W, et al. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers [ J ]. Cornea, 2010,29 : 263 - 268.
  • 10Scuderi AC, De Lazzari A, Miano F, et al. Residence time of netilmicin in tears [ J]. Cornea, 2002,21:48 -50.

二级参考文献9

共引文献15

同被引文献36

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部